ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
ACRO BIOMEDICAL CO., LTD.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $1.56M
- P/E (TTM)
- –
- Dividend yield
- –
ACRO BIOMEDICAL CO., LTD. balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- 29.7%
Financial strength
- Current ratio
- 0.01
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 0.8%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –